Detalles de la búsqueda
1.
Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL).
Lancet
; 401(10370): 25-37, 2023 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36493791
2.
Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE).
Lancet
; 401(10370): 38-48, 2023 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36495881
3.
Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis: 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL study.
Ann Rheum Dis
; 82(11): 1404-1414, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37696588
4.
Astroglial Plasticity Is Implicated in Hippocampal Remodelling in Adult Rats Exposed to Antenatal Dexamethasone.
Neural Plast
; 2015: 694347, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26345609
5.
Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas.
J Pathol
; 231(4): 424-32, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24122851
6.
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL.
RMD Open
; 10(1)2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38388171
7.
Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups.
Histopathology
; 62(6): 860-75, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23509938
8.
Safe and Effective Subcutaneous Self-Injection of Bimekizumab with Safety Syringe and Auto-Injector Devices: Results from a Multicenter, Randomized, Open-Label Study in Patients with Psoriatic Arthritis.
Patient Prefer Adherence
; 17: 2451-2461, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37808274
9.
BRAF(V600E) mutations are found in Richter syndrome and may allow targeted therapy in a subset of patients.
Br J Haematol
; 170(2): 282-5, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25758903
10.
Brand-Specific Enhanced Safety Surveillance of GSK's Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season.
Drug Saf
; 43(3): 265-279, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31884676
11.
Brand-specific enhanced safety surveillance of GSK's Fluarix Tetra seasonal influenza vaccine in England: 2017/2018 season.
Hum Vaccin Immunother
; 16(8): 1762-1771, 2020 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32118513
12.
Enhanced Safety Surveillance of GSK's Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain for the 2018/19 Season: Interim Analysis.
Adv Ther
; 36(12): 3340-3355, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31595482
13.
Passive enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccine in Belgium, Germany and Spain, an observational study: protocol for the 2018/2019 influenza season.
BMJ Open
; 9(8): e028043, 2019 08 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31427321
14.
BRAF V600E mutation-specific antibody, a sensitive diagnostic marker revealing minimal residual disease in hairy cell leukaemia.
Br J Haematol
; 162(6): 848-51, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23848818
15.
Enhanced Safety Surveillance of Seasonal Quadrivalent Influenza Vaccines in English Primary Care: Interim Analysis.
Adv Ther
; 35(8): 1199-1214, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29995300
16.
Intracellular TCR-signaling pathway: novel markers for lymphoma diagnosis and potential therapeutic targets.
Am J Surg Pathol
; 38(10): 1349-59, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25118816
Resultados
1 -
16
de 16
1
Próxima >
>>